Mizuho Increases Cigna Group (NYSE:CI) Price Target to $340.00

Cigna Group (NYSE:CI) had its target price hoisted by investment analysts at Mizuho from $330.00 to $340.00 in a research note issued to investors on Monday,MarketScreener reports. The firm currently has an “outperform” rating on the health services provider’s stock. Mizuho’s price objective suggests a potential upside of 17.79% from the company’s current price.

Several other research firms have also recently commented on CI. Truist Financial raised their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Piper Sandler lowered their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Raymond James Financial set a $340.00 target price on Cigna Group in a research note on Friday, May 1st. Guggenheim raised their price target on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Morgan Stanley lifted their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.80.

Cigna Group Trading Down 0.3%

NYSE:CI opened at $288.65 on Monday. The firm has a market cap of $76.36 billion, a P/E ratio of 12.18, a PEG ratio of 1.12 and a beta of 0.28. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock’s 50 day simple moving average is $279.58 and its 200-day simple moving average is $277.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the company earned $6.74 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. DV Trading LLC grew its stake in shares of Cigna Group by 187.5% in the first quarter. DV Trading LLC now owns 920 shares of the health services provider’s stock valued at $245,000 after buying an additional 600 shares in the last quarter. Parallel Advisors LLC increased its stake in shares of Cigna Group by 26.1% in the first quarter. Parallel Advisors LLC now owns 3,568 shares of the health services provider’s stock worth $952,000 after buying an additional 738 shares during the last quarter. NewEdge Advisors LLC boosted its stake in Cigna Group by 47.8% during the 1st quarter. NewEdge Advisors LLC now owns 34,277 shares of the health services provider’s stock valued at $9,143,000 after acquiring an additional 11,085 shares during the last quarter. Caerus Investment Advisors LLC acquired a new position in Cigna Group during the 1st quarter worth $294,000. Finally, First Nebraska Trust Co acquired a new position in Cigna Group during the 1st quarter worth $204,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.